← Back to headlines
Monopar Therapeutics Directors Sell Hundreds of Thousands in Company Stock
Two directors at Monopar Therapeutics have recently sold substantial blocks of company shares, with transactions totaling nearly $800,000. The sales reflect routine executive divestments reported through standard SEC filing disclosures.
29 Aug, 01:45 — 29 Aug, 01:45
Sources
Showing 1 of 1 sources
